Harrow (HROW) Non-Current Assets (2010 - 2026)

Harrow (HROW) recorded quarterly Non-Current Assets of $193.2 million in Q1 2026, up 2.89% quarter-over-quarter from $187.7 million in Q4 2025, and down 0.76% on a YoY basis from $194.6 million in Q1 2025.

Harrow (HROW) Non-Current Assets (2010 - 2026) Analysis & Trends

Harrow's Non-Current Assets history runs 16 years deep, the most recent figure standing at $193.2 million for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 0.76% year-over-year to $193.2 million; the TTM figure through Mar 2026 stood at $756.5 million (down 1.2% YoY), while the FY2025 annual figure was $187.7 million, down 5.81% from the prior year.
  • Non-Current Assets was $193.2 million for Q1 2026 at Harrow, up from $187.7 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $204.5 million in Q3 2024 to a low of $107000.0 in Q4 2022.
  • Historically, Non-Current Assets has averaged $109.9 million across 5 years, with a median of $170.1 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Assets plunged 74.03% in 2022, then jumped 161285.05% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $107000.0 in 2022, then surged by 161285.05% to $172.7 million in 2023, then advanced by 15.43% to $199.3 million in 2024, then fell by 5.81% to $187.7 million in 2025, then increased by 2.89% to $193.2 million in 2026.
  • The last three Non-Current Assets figures came in at $193.2 million (Q1 2026), $187.7 million (Q4 2025), and $185.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 26.33 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 8.68 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 3.84 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 2.47 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 9.64 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.90 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.22 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.40 Bn
10 Harrow 1.25 Bn 1.15 Bn 27.05 Mn 193.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 193.16 Mn
Dec 31, 2025 187.73 Mn
Sep 30, 2025 185.47 Mn
Jun 30, 2025 190.14 Mn
Mar 31, 2025 194.63 Mn
Dec 31, 2024 199.32 Mn
Sep 30, 2024 204.48 Mn
Jun 30, 2024 167.24 Mn
Mar 31, 2024 170.08 Mn
Dec 31, 2023 172.68 Mn
Sep 30, 2023 780,000.00
Jun 30, 2023 808,000.00
Mar 31, 2023 133,000.00
Dec 31, 2022 107,000.00
Sep 30, 2022 994,000.00
Jun 30, 2022 773,000.00
Mar 31, 2022 360,000.00
Dec 31, 2021 412,000.00
Sep 30, 2021 36,000.00
Jun 30, 2021 43,000.00